Pfizer 25 LLN (Lorbrena 25 mg)
Generic Name: lorlatinib
Pill with imprint Pfizer 25 LLN is Tan, Round and has been identified as Lorbrena 25 mg. It is supplied by Pfizer Inc..
Lorbrena is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Lorbrena 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer 25 LLN
More about Lorbrena (lorlatinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.